Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Molecules ; 23(9)2018 Sep 06.
Artigo em Inglês | MEDLINE | ID: mdl-30200573

RESUMO

Coriolus versicolor is an herb widely used for cancer treatment in traditional Chinese medicine. Its active ingredients, polysaccharopeptides (PSP), have been used for adjuvant therapies in cancer treatment. This study conjugates Coriolus versicolor PSP with poly(ethylenimine) (PEI) to generate a PSP-PEI copolymer for gene transfer. After PEI conjugation, both the pH buffering capacity and DNA compaction ability of PSP are significantly increased. Compared with that of PSP, the transfection efficiency of PSP-PEI is 10 to 20-fold higher in vitro. This is a proof-of-concept study reporting the direct use of bioactive phytochemicals from traditional Chinese medicine for gene vector development. The promising performance of PSP-PEI raises the possibility that bioactive herbal ingredients can be further developed as a multi-therapeutic gene carrier for tackling cancers.


Assuntos
Técnicas de Transferência de Genes , Terapia Genética , Compostos Fitoquímicos/química , Proteoglicanas/química , DNA/química , DNA/uso terapêutico , Humanos , Compostos Fitoquímicos/genética , Polímeros/química , Proteoglicanas/genética , Trametes/química , Trametes/genética , Transfecção
2.
Mol Cancer Ther ; 10(6): 1082-92, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21518728

RESUMO

Interleukin-2 (IL-2) has been shown to possess antitumor activity in numerous preclinical and clinical studies. However, the short half-life of recombinant IL-2 protein in serum requires repeated high-dose injections, resulting in severe side effects. Although adenovirus-mediated IL-2 gene therapy has shown antitumor efficacy, the host antibody response to adenoviral particles and potential biosafety concerns still obstruct its clinical applications. Here we report a novel nanopolymer for IL-2 delivery, consisting of low molecular weight polyethylenimine (600 Da) linked by ß-cyclodextrin and conjugated with folate (named H1). H1 was mixed with IL-2 plasmid to form H1/pIL-2 polyplexes of around 100 nm in diameter. Peritumoral injection of these polyplexes suppressed the tumor growth and prolonged the survival of C57/BL6 mice bearing B16-F1 melanoma grafts. Importantly, the antitumor effects of H1/pIL-2 (50 µg DNA) were similar to those of recombinant adenoviruses expressing IL-2 (rAdv-IL-2; 2 × 10(8) pfu). Furthermore, we showed that H1/pIL-2 stimulated the activation and proliferation of CD8+, CD4+ T cell, and natural killer cells in peripheral blood and increased the infiltration of CD8+, CD4+ Tcells, and natural killer cells into the tumor environment. In conclusion, these results show that H1/pIL-2 is an effective and safe melanoma therapeutic with an efficacy comparable to that of rAdv-IL-2. This treatment represents an alternative gene therapy strategy for melanoma.


Assuntos
Imunoterapia/métodos , Interleucina-2/administração & dosagem , Melanoma Experimental/imunologia , Melanoma Experimental/terapia , Nanopartículas/administração & dosagem , Animais , Linfócitos T CD4-Positivos/metabolismo , Linfócitos T CD8-Positivos/metabolismo , Linhagem Celular Tumoral , Sistemas de Liberação de Medicamentos , Feminino , Ácido Fólico/química , Humanos , Interleucina-2/química , Interleucina-2/genética , Células Matadoras Naturais/metabolismo , Melanoma Experimental/genética , Melanoma Experimental/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Nanopartículas/química , Polietilenoimina/química , Polímeros/química , Polímeros/uso terapêutico , Linfócitos T Auxiliares-Indutores/metabolismo , Transgenes , beta-Ciclodextrinas/química
3.
Integr Cancer Ther ; 10(1): 85-91, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20702496

RESUMO

Chemoresistance has imposed a great challenge for cancer therapy. Fructus Ligustri Lucidi (FLL) is one of the commonest Chinese herbs that has been used for thousand years. This study shows that the aqueous extract of FLL (AFLL) enhanced the sensitivity of DLD-1 colon cancer cells to doxorubicin-induced apoptosis. Furthermore, Tbx3 expression was found to be suppressed by AFLL when the expression of tumor suppressor genes p14 and p53 were activated. Therefore, reduction of Tbx3 rescued the dysregulated P14(ARF)-P53 signaling, which in turn contributed to the sensitivity of DLD-1 cells to doxorubicin-induced apoptosis. As a conclusion, the findings suggest that FLL has a potential of being an appealing agent for auxiliary chemotherapy in treatment of human colorectal carcinoma.


Assuntos
Apoptose/efeitos dos fármacos , Neoplasias Colorretais/tratamento farmacológico , Doxorrubicina/farmacologia , Ligustrum/química , Extratos Vegetais/farmacologia , Proteínas com Domínio T/antagonistas & inibidores , Antibióticos Antineoplásicos/farmacologia , Processos de Crescimento Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Neoplasias Colorretais/genética , Neoplasias Colorretais/metabolismo , Neoplasias Colorretais/patologia , Sinergismo Farmacológico , Humanos , Extratos Vegetais/química , RNA Interferente Pequeno/administração & dosagem , RNA Interferente Pequeno/genética , Proteínas com Domínio T/biossíntese , Proteínas com Domínio T/genética , Transfecção , Proteína Supressora de Tumor p14ARF/genética , Proteína Supressora de Tumor p14ARF/metabolismo , Proteína Supressora de Tumor p53/genética , Proteína Supressora de Tumor p53/metabolismo
4.
World J Gastroenterol ; 15(24): 2987-94, 2009 Jun 28.
Artigo em Inglês | MEDLINE | ID: mdl-19554651

RESUMO

AIM: To test whether oral L-81 treatment could improve the condition of mice with diabetes and to investigate how L-81 regulates microsomal triglyceride transfer protein (MTP) activity in the liver. METHODS: Genetically diabetic (db/db) mice were fed on chow supplemented with or without L-81 for 4 wk. The body weight, plasma glucose level, plasma lipid profile, and adipocyte volume of the db/db mice were assessed after treatment. Toxicity of L-81 was also evaluated. To understand the molecular mechanism, HepG2 cells were treated with L-81 and the effects on apolipoprotein B (apoB) secretion and mRNA level of the MTP gene were assessed. RESULTS: Treatment of db/db mice with L-81 significantly reduced and nearly normalized their body weight, hyperphagia and polydipsia. L-81 also markedly decreased the fasting plasma glucose level, improved glucose tolerance, and attenuated the elevated levels of plasma cholesterol and triglyceride. At the effective dosage, little toxicity was observed. Treatment of HepG2 cells with L-81 not only inhibited apoB secretion, but also significantly decreased the mRNA level of the MTP gene. Similar to the action of insulin, L-81 exerted its effect on the MTP promoter. CONCLUSION: L-81 represents a promising candidate in the development of a selective insulin-mimetic molecule and an anti-diabetic agent.


Assuntos
Proteínas de Transporte/metabolismo , Diabetes Mellitus Experimental/tratamento farmacológico , Regulação da Expressão Gênica/efeitos dos fármacos , Poloxâmero , Tensoativos , Animais , Proteínas de Transporte/genética , Linhagem Celular , Colesterol/sangue , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Experimental/fisiopatologia , Ingestão de Líquidos/efeitos dos fármacos , Ingestão de Alimentos/efeitos dos fármacos , Humanos , Hipoglicemiantes/farmacologia , Hipoglicemiantes/uso terapêutico , Fígado/citologia , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Poloxâmero/farmacologia , Poloxâmero/uso terapêutico , Rosiglitazona , Tensoativos/farmacologia , Tensoativos/uso terapêutico , Tiazolidinedionas/farmacologia , Tiazolidinedionas/uso terapêutico , Triglicerídeos/sangue , Redução de Peso/efeitos dos fármacos
5.
J Biol Chem ; 283(22): 15142-51, 2008 May 30.
Artigo em Inglês | MEDLINE | ID: mdl-18364351

RESUMO

HspA, a member of the GroES chaperonin family, is a small protein found in Helicobacter pylori with a unique histidine- and cysteine-rich domain at the C terminus. In this work, we overexpressed, purified, and characterized this protein both in vitro and in vivo. The apo form of the protein binds 2.10 +/- 0.07 Ni(2+) or 1.98 +/- 0.08 Bi(3+) ions/monomer with a dissociation constant (K(d)) of 1.1 or 5.9 x 10(-19) microm, respectively. Importantly, Ni(2+) can reversibly bind to the protein, as the bound nickel can be released either in the presence of a chelating ligand, e.g. EDTA, or at an acidic pH (pH((1/2)) 3.8 +/- 0.2). In contrast, Bi(3+) binds almost irreversibly to the protein. Both gel filtration chromatography and native electrophoresis demonstrated that apo-HspA exists as a heptamer in solution. Unexpectedly, binding of Bi(3+) to the protein altered its quaternary structure from a heptamer to a dimer, indicating that bismuth may interfere with the biological functions of HspA. When cultured in Ni(2+)-supplemented M9 minimal medium, Escherichia coli BL21(DE3) cells expressing wild-type HspA or the C-terminal deletion mutant clearly indicated that the C terminus might protect cells from high concentrations of external Ni(2+). However, an opposite phenomenon was observed when the same E. coli hosts were grown in Bi(3+)-supplemented medium. HspA may therefore play a dual role: to facilitate nickel acquisition by donating Ni(2+) to appropriate proteins in a nickel-deficient environment and to carry out detoxification via sequestration of excess nickel. Meanwhile, HspA can be a potential target of the bismuth antiulcer drug against H. pylori.


Assuntos
Proteínas de Bactérias/química , Bismuto/química , Chaperoninas/química , Proteínas de Choque Térmico/química , Helicobacter pylori/química , Metaloproteínas/química , Níquel/química , Proteínas de Bactérias/genética , Proteínas de Bactérias/isolamento & purificação , Proteínas de Bactérias/metabolismo , Bismuto/uso terapêutico , Chaperoninas/genética , Chaperoninas/isolamento & purificação , Chaperoninas/metabolismo , Dimerização , Ácido Edético/química , Escherichia coli/crescimento & desenvolvimento , Proteínas de Choque Térmico/genética , Proteínas de Choque Térmico/isolamento & purificação , Proteínas de Choque Térmico/metabolismo , Infecções por Helicobacter/tratamento farmacológico , Infecções por Helicobacter/genética , Infecções por Helicobacter/metabolismo , Helicobacter pylori/genética , Helicobacter pylori/metabolismo , Histidina/química , Histidina/genética , Histidina/metabolismo , Concentração de Íons de Hidrogênio , Metaloproteínas/genética , Metaloproteínas/isolamento & purificação , Metaloproteínas/metabolismo , Níquel/metabolismo , Níquel/farmacologia , Ligação Proteica/fisiologia , Estrutura Quaternária de Proteína , Estrutura Terciária de Proteína/fisiologia , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/metabolismo
6.
Biologics ; 2(3): 571-6, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19707387

RESUMO

We evaluated the antidiabetic effects of a mixed vegetable powder-formula I (MVP-FI), which is a dry powder mixture of over 65 kinds of vegetables and fruits, using the db/db type 2 diabetes mouse model. The db/db mice at 8-10 weeks of age were randomly divided into three groups: vehicle treatment, 1.575 g/kg MVP-FI treatment, and 3.15 g/kg MVP-FI treatment. During 12 days of treatment, we measured food intake and body weight changes, fasting blood glucose levels, and plasma lipid levels. Our results showed that the food intake and the body weight of MVP-FI-treated group were decreased gradually. Moreover, the fasting blood glucose level of the treated group was significantly dropped to a normal level comparable to that of the lean mice. Furthermore, we also found that the plasma triglyceride level in the treated group was dropped, whereas the high-density lipoprotein (HDL) level was increased and total cholesterol/HDL-cholesterol ratio was decreased. Taken together, these results suggest that the diabetic conditions of the db/db mice have been improved after 12 days treatment with MVP-FI. The antihyperglycemic and antiobese activities of the MVP-FI, as demonstrated in the present study, may have important clinical implications for improving the management of type 2 diabetic patients.

7.
Childs Nerv Syst ; 23(10): 1119-24, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17450368

RESUMO

OBJECTIVE: This paper aims to understand the situation and epidemiology trend of neural tube defects in Guizhou province, China from 1996 to 2004. STUDY DESIGN: Pregnant women from 17 hospitals in Guizhou province were chosen for investigation of perinatal infants from January 1996 to December 2004. RESULTS: Of 1,208 birth defect cases studied in this 9-year period, a total of 122 cases were identified as neural tube defects (NTD), making up a 10.10% of the total birth defects. The average prevalence rate of NTD was 12.21 per 10,000 births; however, there is no significant difference between the genders. In this study, the age of mothers during pregnancy was shown to be one of the major factors affecting the prevalence rate of NTD and the differences between infants with or without NTD and the usage of folic acid as a supplement during pregnancy were found to be statistical significant. CONCLUSION: NTD was found to be the most common and serious form of human birth defect in Guizhou province. For prevention, folic acid supplement is thought to be efficacious in inhibiting NTD, and thus, it is essential for people in socially deprived areas to effectively reduce the prevalence of NTD in China.


Assuntos
Defeitos do Tubo Neural/epidemiologia , Áreas de Pobreza , Adulto , Fatores Etários , Anencefalia/epidemiologia , Peso ao Nascer/fisiologia , China/epidemiologia , Anormalidades Congênitas/epidemiologia , Encefalocele/epidemiologia , Feminino , Ácido Fólico/uso terapêutico , Idade Gestacional , Humanos , Recém-Nascido de Baixo Peso , Recém-Nascido , Idade Materna , Defeitos do Tubo Neural/prevenção & controle , Gravidez , Disrafismo Espinal/epidemiologia
8.
Endocrine ; 29(1): 161-7, 2006 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16622306

RESUMO

Cyclooxygenase (COX)-2 is an inducible isoform, expressed in inflamed leukocytes and cancer cells. It is known that estrogen causes prostate dysplasia, but little is known about COX-2 expression and its influence on male reproductivity. In this study, we show that COX-2 was abolished in the distal end of the vas deferens in neonatally estrogenized (diethylstilbestrol, NeoDES) Sprague-Dawley (SD) rats at age of 15 mo, but the control normal rats were found to remain constitutive expression at the same age, while the levels of COX-1 in these rats remained intact. Furthermore, BAX, an indicator of sperm quality, was observed in the endothelium of vas deferens and sperm of the aged rats. However, COX-2 was not detected in the inflamed lesions of NeoDES rat's prostate by immunohistochemistry. In addition to estrogen, hydroxymatairesinol (HMR), a phytoestrogen, was analyzed in vitro for possible regulation on COX-2. Through Western blot analysis, HMR was shown to have no inhibitory affect on COX-2 expression. These results indicated that estrogen treatment strongly influences the expression of COX-2 that is associated with fertility, but no induction of COX-2 by estrogen may not exclude COX-2's role in prostatitis, and the anti-tumor mechanism of HMR largely remains elusive.


Assuntos
Ciclo-Oxigenase 1/genética , Ciclo-Oxigenase 2/genética , Estrogênios/farmacologia , Genitália Masculina/efeitos dos fármacos , Macrófagos/efeitos dos fármacos , Proteínas de Membrana/genética , Fitoestrógenos/farmacologia , Animais , Animais Recém-Nascidos , Western Blotting , Linhagem Celular , Senescência Celular/genética , Ciclo-Oxigenase 1/análise , Ciclo-Oxigenase 2/análise , Dietilestilbestrol/farmacocinética , Indução Enzimática/efeitos dos fármacos , Indução Enzimática/fisiologia , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Genitália Masculina/química , Genitália Masculina/citologia , Imuno-Histoquímica , Lignanas/farmacologia , Lipopolissacarídeos/farmacologia , Ativação de Macrófagos/efeitos dos fármacos , Ativação de Macrófagos/fisiologia , Macrófagos/química , Macrófagos/fisiologia , Masculino , Proteínas de Membrana/análise , Próstata/química , Próstata/citologia , Próstata/efeitos dos fármacos , Ratos , Espermatozoides/química , Espermatozoides/citologia , Espermatozoides/efeitos dos fármacos , Ducto Deferente/química , Ducto Deferente/citologia , Ducto Deferente/efeitos dos fármacos , Proteína X Associada a bcl-2/análise
9.
J Nutr ; 132(6): 1165-8, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12042427

RESUMO

Epidemiologic studies have suggested that fresh garlic has lipid-lowering activity. Because the microsomal triglyceride transfer protein (MTP) plays a pivotal role in the assembly and secretion of apolipoprotein B (apoB)-containing lipoproteins, we evaluated the effect of garlic on the expression of the MTP gene in vitro in cell lines and in vivo in rats. Fresh garlic extract (FGE) reduced MTP mRNA levels in both the human hepatoma HepG2 and intestinal carcinoma Caco-2 cells in dose-dependent fashion; significant reductions were detected with 3 g/L FGE. Maximal 72 and 59% reductions, respectively, were observed with 6 g/L FGE. To evaluate the in vivo effect of garlic on MTP gene expression, rats were given a single oral dose of fresh garlic homogenate (FGH), with hepatic and intestinal MTP mRNA measured 3 h after dosing. Rats fed FGH had significantly (46% of the control) lower intestinal MTP mRNA levels compared with the control rats, whereas hepatic MTP mRNA levels were not affected. These results suggest a new mechanism for the hypolipidemic effect of fresh garlic. Long-term dietary supplementation of fresh garlic may exert a lipid-lowering effect partly through reducing intestinal MTP gene expression, thus suppressing the assembly and secretion of chylomicrons from intestine to the blood circulation.


Assuntos
Proteínas de Transporte/antagonistas & inibidores , Alho/química , Regulação da Expressão Gênica/fisiologia , Mucosa Intestinal/metabolismo , Fígado/metabolismo , Extratos Vegetais/farmacologia , Animais , Apolipoproteínas B/metabolismo , Células CACO-2 , Relação Dose-Resposta a Droga , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Ratos , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA